Donor Simvastatin Treatment is Safe and Might Ameliorate Outcomes after Liver Transplantation: A Randomized Phase II Double-Blind Clinical Trial.

Authors :: Pagano, Duilio
Cintorino, Davide
Li Petri, Sergio
Ricotta, Calogero
Bonsignore, Pasquale
Calamia, Sergio
Gruttadauria, Salvatore
Source :: Journal of the American College of Surgeons (2563-9021). 2022 Supplement, Vol. 235, pS86-S86. 1p.
Publication Year :: 2022

Subjects :: *CONFERENCES & conventions
*TREATMENT effectiveness
*LIVER diseases
*SIMVASTATIN
*POSTOPERATIVE period
*LIVER transplantation
*PATIENT safety

Full Text Access

Tools